wordpress blog stats
Connect with us

Hi, what are you looking for?

, , ,

Practo-Thyrocare to provide bookings for COVID-19 home tests

Online consultation and e-pharmacy platform Practo has partnered with private laboratory Thyrocare to provide COVID-19 home tests in Mumbai. Navi Mumbai company Thyrocare — among 49 private laboratories approved by the Indian Council of Medical Research (ICMR) for COVID-19 testing — is authorised to conduct tests in Maharashtra. Practo declined to disclose to MediaNama the number of tests done so far.

Practo said it will soon expand tests to the rest of the country. The company will likely do so in partnership with other ICMR-approved private testing labs, which are situated across 11 states, including Maharashtra, Karnataka, Telangana, Tamil Nadu, Kolkata, among others. Practo told MediaNama it is too early too comment on this.

How the tests will be done: People can book the tests — capped by the Health Ministry at a cost of Rs 4,500 — on either Practo or Thyrocare. They will have to provide a doctor’s prescription along with a Test Requisition Form, and their photo ID. This is in line with the ICMR’s private testing guidelines, which mandate private labs to collect contact information of the patients to enable contact tracing.

How samples will be collected, and precautions: Certified phelobotomists — physicians who draw blood from patients — from healthcare company I2H Solutions will collect the samples from the patients’ home directly, and will take all “necessary precautions” in the ICMR guidelines while taking swabs, Practo said. The Practo app says a trained lab technician wearing a single-use bio-hazard suit will be sent to collect the sample. India does not have its own bio-safety standards, so it’s unclear why Practo is following this particular protocol. The company simply told us that it’s following the ICMR guidelines, but even those say that “appropriate biosafety and biosecurity precautions should be ensured” while collecting samples, without going into specifics.

The swabs will be transported in a cold chain to the Thyrocare lab, results will be available within 48 hours but this is subject to government regulations. The lab may also share the report with the authorised government bodies, Practo said, in line with ICMR guidlelines that private laboratories have to report the number of tests conducted in real-time to ICMR. 

Advertisement. Scroll to continue reading.

Sharing of samples: Government guidelines for private labs also require that the patient’s samples are not shared with any other organisation. It’s unclear who will be responsible for ensuring this, as three different entities are involved in Practo’s testing — Practo, I2H, and Thyrocare. We did not receive a clear answer from Practo on this, instead the company simply said it is committed to ensuring that all guidelines are adhered to. 

Issues faced during testing: Last week, Thyrocare ran into roadblocks during its first day of home tests in Mumbai. Only 30 out of the 3,000 people who booked tests agreed to get tested. 27 people out of those refused to get tested because the technician was wearing protective gear, fearing stigma from neighbours. Eventually, only 3 tests were conducted. Practo told us that its phlebotomists were not able to move around due to the lockdown, but the company is working with authorities for permissions.

Within a week of the nationwide lockdown, India has seen a spike in the number of COVID-19 cases, with 1,251 positive cases and 32 deaths so far. Of these, 227 cases and 5 deaths were reported in the last 24 hours. The Indian government has also identified 10 hotspots, where unusually high numbers of transmission have been seen, while maintaining that there has been no or “limited” community transmission. 

Written By

I cover health, policy issues such as intermediary liability, data governance, internet shutdowns, and more. Hit me up for tips.

MediaNama’s mission is to help build a digital ecosystem which is open, fair, global and competitive.



Looking at the definition of health data, it is difficult to verify whether health IDs are covered by the Bill.


The accession to the Convention brings many advantages, but it could complicate the Brazilian stance at the BRICS and UN levels.


In light of the state's emerging digital healthcare apparatus, how does Clause 12 alter the consent and purpose limitation model?


The collective implication of leaving out ‘proportionality’ from Clause 12 is to provide very wide discretionary powers to the state.


The latest draft is also problematic for companies or service providers that have nothing to with children's data.

You May Also Like


Google has released a Google Travel Trends Report which states that branded budget hotel search queries grew 179% year over year (YOY) in India, in...


135 job openings in over 60 companies are listed at our free Digital and Mobile Job Board: If you’re looking for a job, or...


Rajesh Kumar* doesn’t have many enemies in life. But, Uber, for which he drives a cab everyday, is starting to look like one, he...


By Aroon Deep and Aditya Chunduru You’re reading it here first: Twitter has complied with government requests to censor 52 tweets that mostly criticised...

MediaNama is the premier source of information and analysis on Technology Policy in India. More about MediaNama, and contact information, here.

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ

Subscribe to our daily newsletter
Your email address:*
Please enter all required fields Click to hide
Correct invalid entries Click to hide

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ